In the first edition of our paediatric webinar series, held April 7, we started to review the current state of the art and continue to share experiences from the PED in highly impacted countries; France, Spain and Italy. It was a very interesting webinar, with many participants and a lot of questions answered. 

The recording is now available on the EUSEM Academy: Guidance on COVID-19 in Paediatrics Open access for everybody.

The PDF's and Q&A will be shared here as well soon. 

With a special thanks to Ruud Nijman, Roberto Velasco and Luigi Titomanlio for organising this.

Please note that if you login with your EUSEM account, you can ask questions in the forum and exchange experiences or suggest topics for upcoming webinars. So let's share that information!
When logged in you have access to much more material.

You'll find the webinar from March 28 there as well: COVID-19, A Unique Insight from Highly Impacted Countries 

SAVE THE DATE!: The next webinar will be held on the 24th of April at 14:00 CEST.


Guidance on the management of clinical trials during the COVID-19 (coronavirus) pandemic

We would like to bring to your attention the publication of the “guidance on the management of clinical trials during the COVID-19 (coronavirus) pandemic”.

The European Medicines Agency, Good Clinical Practice (GCP) Inspectors Working Group, the Clinical Trials Facilitation and Coordination Group (CTFG, a working group of the Heads of Medicines Agency (HMA)), the Clinical Trials Expert Group (CTEG, a working group of the European Commission representing Ethics Committees and National Competent Authorities) and the European Commission (EC) acknowledge the impact of COVID-19 on the health system and broader society, and the impact it may have on clinical trials and trial participants. Extraordinary measures may need to be implemented and trials adjusted due to e.g. trial participants being in self-isolation/quarantine, limited access to public places (including hospitals) due to the risk of spreading infections, and health care professionals being committed to critical tasks. Therefore, EMA, EC and HMA strongly support the efforts of the GCP Inspectors’ Working Group for developing a harmonised EU/EEA-level guidance to mitigate the negative effects of the COVID-19 pandemic on the conduct of clinical trials.

The situation is evolving, and pragmatic actions may be required to deal with the challenges of conducting research, and in ensuring the rights, safety and wellbeing of participants. The points mentioned below are intended to provide guidance for all parties involved in clinical trials during this time.

Due to the urgency, this guidance is issued without prior public consultation. The sponsors should note that due to the rapidly evolving situation further updates to this guidance are possible and likely.


COVID-19: EJEM articles published ahead of print!

Sharing information on Covid-19 is extremely important right now. That's why we would like to share these articles from the Published Ahead of Print page of the European Journal of Emergency Medicine, https://journals.lww.com/euro-emergencymed/Citation/publishahead/ 

COVID-19: emergency medicine perspectives from Hong Kong
Hung, Kevin K.C.; Walline, Joseph H.; Graham, Colin A.

COVID-19: response plan for International Medical Assistance companies

François-Xavier Duchateau, Geoffrey Ramin and Anne Lepetit

COVID-19: one threat, one world, one response (magical thinking)
Òscar Miró 

How emergency departments prepare for virus disease outbreaks like COVID-19
Martin Möckel, Ulrike Bachmann, Wilhelm Behringer,Frieder Pfäfflin and Miriam Songa Stegemann

COVID-19, a UK perspective
Joanna Sriskandar and Benjamin Bloom



Abstract submission period prolonged

NEW DATE: 30 April 2020 - Midnight (CEST) +02:00 UTC 

While we are all facing an exceptional situation due to the impact of COVID-19 in Europe and worldwide, we are all aware that your time is precious at the moment and highly dedicated to your hospital. EUSEM consequently decided to prolong the abstract submission period to 30 April 2020. 

We all hope the situation will get better very soon and we will all see you in Copenhagen in September!


Lessons learned from Italy

COVID-19 is one of the greatest challenges that the entire World is called to face since the dark years of the Second World War.

In this time of uncertainty and fear, it is necessary to maintain clarity and reiterate the principle of science, knowledge and, above all, expertise.

In this regard, there is an ongoing commitment by SIMEU, the Italian scientific society made up of the doctors and nurses in the Emergency Medicine departments operating in the approximately 650 Emergency Rooms throughout Italy.

As widely known, Italy has been the first European Country called to cope with the extreme COVID-19 emergency which has overturned all the usual procedural practices. SIMEU immediately acted to promote the circulation of knowledge by sharing working documents based on various field experiences, and published them on THIS WEBSITE to benefit its members.

SIMEU also deems it useful to disclose these documents to the international audience.

Documenting the real healthcare emergency flows as well as the adopted solutions and bringing them to the attention of the collegues around the World is the most effective assistance SIMEU can provide to help them in developing a more efficient organizational model suited for the new needs.

Taking an optimistic look at the situation, one side effect of the sacrifice and the efforts of those who "got there first" is that they are able to provide concrete help to those who come later making them better prepared.

We wish to convey this optimistic know-how to all our colleagues who may take advantage of it. We all can get through this, together!


Dr Salvatore Manca _ President